Brought to you by

Roche licenses Japan Tobacco's lipid agent; terminated
21 Sep 2012
Executive Summary
Roche is licensing exclusive rights to develop and commercialize Japan Tobacco's lipid-modifying agent JTT705 in all markets outside Japan and Korea.
Deal Industry
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement